Pet Pharm Biotech Co., Ltd. (TPEX:7762)

Pet Pharm Biotech Statistics

Total Valuation

TPEX:7762 has a market cap or net worth of TWD 4.34 billion. The enterprise value is 3.94 billion.

Market Cap	4.34B
Enterprise Value	3.94B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Aug 25, 2025

Share Statistics

TPEX:7762 has 51.21 million shares outstanding. The number of shares has increased by 92.45% in one year.

Current Share Class	51.21M
Shares Outstanding	51.21M
Shares Change (YoY)	+92.45%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.42%
Owned by Institutions (%)	3.36%
Float	35.42M

Valuation Ratios

The trailing PE ratio is 206.65.

PE Ratio	206.65
Forward PE	n/a
PS Ratio	27.27
PB Ratio	4.85
P/TBV Ratio	4.89
P/FCF Ratio	n/a
P/OCF Ratio	122.36
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 100.54, with an EV/FCF ratio of -34.42.

EV / Earnings	204.66
EV / Sales	24.77
EV / EBITDA	100.54
EV / EBIT	n/a
EV / FCF	-34.42

Financial Position

The company has a current ratio of 4.40, with a Debt / Equity ratio of 0.19.

Current Ratio	4.40
Quick Ratio	4.28
Debt / Equity	0.19
Debt / EBITDA	4.44
Debt / FCF	-1.52
Interest Coverage	44.77

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	1.01%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +125.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+125.71%
50-Day Moving Average	67.04
200-Day Moving Average	56.03
Relative Strength Index (RSI)	75.15
Average Volume (20 Days)	260,162

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:7762 had revenue of TWD 159.02 million and earned 19.25 million in profits. Earnings per share was 0.41.

Revenue	159.02M
Gross Profit	82.91M
Operating Income	9.67M
Pretax Income	17.16M
Net Income	19.25M
EBITDA	31.73M
EBIT	9.67M
Earnings Per Share (EPS)	0.41

Balance Sheet

The company has 571.69 million in cash and 174.02 million in debt, giving a net cash position of 397.67 million or 7.77 per share.

Cash & Cash Equivalents	571.69M
Total Debt	174.02M
Net Cash	397.67M
Net Cash Per Share	7.77
Equity (Book Value)	895.03M
Book Value Per Share	17.48
Working Capital	486.56M

Cash Flow

In the last 12 months, operating cash flow was 35.45 million and capital expenditures -149.91 million, giving a free cash flow of -114.46 million.

Operating Cash Flow	35.45M
Capital Expenditures	-149.91M
Free Cash Flow	-114.46M
FCF Per Share	-2.24

Margins

Gross margin is 52.13%, with operating and profit margins of 6.08% and 12.11%.

Gross Margin	52.13%
Operating Margin	6.08%
Pretax Margin	10.79%
Profit Margin	12.11%
EBITDA Margin	19.95%
EBIT Margin	6.08%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 0.10%.

Dividend Per Share	0.09
Dividend Yield	0.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	41.76%
Buyback Yield	-92.45%
Shareholder Yield	-92.35%
Earnings Yield	0.44%
FCF Yield	-2.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 25, 2025. It was a forward split with a ratio of 1.013420847.

Last Split Date	Aug 25, 2025
Split Type	Forward
Split Ratio	1.013420847

Scores

TPEX:7762 has an Altman Z-Score of 6.9 and a Piotroski F-Score of 4.

Altman Z-Score	6.9
Piotroski F-Score	4